di Reumatologia, Società Italiana, trans. 2026. “PO:24:063 | Interstitial Lung Disease in Idiopathic Inflammatory Myopathy Patients: Efficacy and Safety of Nintedanib: Giulia Buonsante1|2|3, Giacomo De Luca1|2|3, Veronica Batani1|2, Lorenzo Dagna1|2|3, Marco Matucci-Cerinic1|2|3, Corrado Campochiaro1|2|3 | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital Milano, Italy; 2Inflammation, Fibrosis and Aging Initiative INFLAGE, IRCCS San Raffaele Hospital Milano, Italy; 3Vita-Salute San Raffaele University, Milano, Italy”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.2350.